Monkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It was published today as a Special Report by the Foreign Policy Association on the organization’s Web site.
Read More about Monkeypox: The Next Healthcare Challenge – Understanding and Reckoning With It – A Foreign Policy Association Special Report
Serious thought should be given to the effect the anticipated Federal Reserve 0.75% rate hike will have on the biotechnology industry and consequently on the health of the nation.
Read More about In The Fed’s Inflation Fight, Biotech May Be The First CasualtyCan the New CDC meet the monkeypox challenge? What will happen when your child’s school reports the first case of monkeypox? It isn’t a question of if, it’s a question of when. Monkeypox may not be lethal, but it’s both debilitating and disfiguring. What can be done to prevent or mitigate the harm?
Read More about Can The “New” CDC Meet The Monkeypox Challenge?
Steve Brozak, Managing Partner and President of WBB Securities participated as a panelist at the FPA dialogue about the future of the U.S. and the global economy
Read More about FPA: “U.S. Economic Outlook: Continued Growth or Recession?”
Far from cause for celebration, this 4th of July marks the 6th wave of Covid-19, with BA.4 and BA.5 variants leading the parade.
Read More about 5 Musts To Achieve Covid-19 Independence
This week, when the CDC’s vaccine advisory committee considers approving the Moderna and Pfizer/BioNTech mRNA Covid-19 vaccines for infants and toddlers, the issue of imprinting may not be on the agenda.
Read More about Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers